Sanofi Hosts Regional Webinar on Protecting High-Risk Groups from Seasonal Influenza
Tuesday, 20 May 2025
Sanofi recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance of Flu Prevention and Effective Communication," bringing together 380 healthcare professionals from South-East Asia and India to address influenzas impact on vulnerable populations.*Panel session*The symposium highlighted seasonal influenzas disproportionate effects on high-risk groups, particularly adults aged 65+, and those with chronic conditions like diabetes and cardiovascular diseases. *Prof. Sasisopin Kiertiburanakul, from Mahidol University and Vice President of the Infectious Disease Association of Thailand* delivered the keynote on regional influenza epidemiology.
Recent WHO data shows influenza affects approximately 1 billion people annually worldwide. with 3-5 million severe cases, resulting in 290,000-650,000 deaths globally.
"These figures are particularly alarming for vulnerable populations. Influenza can trigger severe complications including pneumonia, myocardial infarction, worsen existing conditions and lead to death," said *Prof. Sasisopin Kiertiburanakul. *"Safeguarding vulnerable people with flu vaccination is safe and effective. Evidence shows it significantly reduces hospitalizations and mortality among our most vulnerable people. It represents a sound investment in public health."
The event featured interactive sessions where medical experts from Thailand, Malaysia and Vietnam discussed the critical importance of influenza vaccination for high-risk groups, including people with cardiovascular disease, diabetes, and older adults. Despite diverse attitudes towards vaccines, experts emphasized that improving access to flu immunization and implementing effective, evidence-based communication strategies are key to reach WHOs target of 75% influenza vaccination coverage among high-risk populations.
"At Sanofi, we believe protecting vulnerable groups against flu requires a well-rounded approach. Through this symposium, were empowering healthcare professionals with the tools and knowledge they need to better protect those most at risk in our communities," emphasized *Ruby Dizon, Vaccines Medical Head of Sanofi Southeast Asia and India.*
Participants gained practical insights on addressing common misconceptions about influenza prevention and learned techniques for framing conversations around the specific benefits for high-risk patients. The symposium concluded with a call to action urging healthcare professionals to unite in protecting vulnerable groups through appropriate flu vaccination.
For high-risk individuals, protection against influenza isnt just a routine health measure-its protection beyond flu including against potentially devastating complications. Through this initiative, Sanofi continues its commitment to reducing the global burden of influenza by supporting healthcare professionals with evidence-based strategies and combating misinformation about flu vaccinations to improve quality of life.
|
||||
|
|
||||
You Might Like |
||||
